← Leaderboards
Amanda C Winters
University Of Colorado Denver
$683,699
Attributed
$683,699
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $227.9K · FY2023–25$250K$187.5K$125K$62.5K$0
'23
'24
'25
Funding mix
By agency
NIH$683,699 · 1
By mechanism
K08$683,699 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Thomas J Crowley$10,535,347
- Allison Kempe$17,039,467
- Douglas K Graham$6,579,169
- Joseph T Sakai$3,604,028
- Kelly Roberta Moore$2,258,667
Others in their field
Other Rising Stars on “Acute Myelocytic Leukemia”
- Michael E. Roth · Public Health Institute$8,303,012
- Javier Caravaca · University Of California, San Francisco$3,728,080
- Kellie Bickel · Twinstrand Biosciences, Inc.$2,555,383
- Jeevisha Bajaj · University Of Rochester$2,438,184
- Bruno Di Stefano · Baylor College Of Medicine$2,398,360
- Angela Goffredo Fleischman · University Of California-Irvine$2,306,090
Research focus
Acute Myelocytic LeukemiaAdolescent PatientAdolescent And Young AdultAdult Acute Lymphocytic LeukemiaAdult Acute Myeloblastic LeukemiaAftercareAllogenicAmerican Society Of HematologyAreaAssay DevelopmentBioinformaticsBiological SciencesBone MarrowBone Marrow TransplantationBurden Of IllnessCareerCause Of DeathCbfa2t1 GeneChemotherapyChildChildhoodChildhood Acute Myeloid LeukemiaChimerismClinical Trials Design
Grant awards (3)
Preclinical Validation of Personalized Molecular Assays for Measurable Residual Disease Monitoring in Pediatric AML$227,889
K08 · FY2025 · CA · contact PI
Preclinical Validation of Personalized Molecular Assays for Measurable Residual Disease Monitoring in Pediatric AML$227,905
K08 · FY2024 · CA · contact PI
Preclinical Validation of Personalized Molecular Assays for Measurable Residual Disease Monitoring in Pediatric AML$227,905
K08 · FY2023 · CA · contact PI